MYCN and neuroblastoma: Delehouzé et al. demonstrated that the CDK inhibitors (R)-roscovitine and (S)-CR8 significantly reduce MYCN expression by blocking CDK7/9/12 and verified this effect in MNA-NB cells and a mouse transplant model (Delehouzé et al., 2014).